Compare WKHS & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WKHS | CLGN |
|---|---|---|
| Founded | 2007 | 2004 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.4M | 18.4M |
| IPO Year | N/A | N/A |
| Metric | WKHS | CLGN |
|---|---|---|
| Price | $3.82 | $0.66 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $21.00 | $11.00 |
| AVG Volume (30 Days) | 100.1K | ★ 113.3K |
| Earning Date | 03-30-2026 | 03-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,895,809.00 | $2,475,000.00 |
| Revenue This Year | $81.01 | $1,596.12 |
| Revenue Next Year | $34.00 | $85.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 280.77 |
| 52 Week Low | $3.78 | $0.59 |
| 52 Week High | $90.63 | $4.98 |
| Indicator | WKHS | CLGN |
|---|---|---|
| Relative Strength Index (RSI) | 32.15 | 25.56 |
| Support Level | $4.16 | $0.66 |
| Resistance Level | $5.00 | $1.99 |
| Average True Range (ATR) | 0.27 | 0.15 |
| MACD | -0.13 | -0.12 |
| Stochastic Oscillator | 4.88 | 5.00 |
Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.